Orthobiologics Market: Viscosupplements Product Type Segment to Gain Traction by the End of the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)
- REP-GB-786
- 2017-11-16
- Category: Healthcare, Pharmaceuticals and Medical devices
- 282 Pages
- Format:
According to the research report published by Future Market Insights, the global orthobiologics market is expected grow at a slow rate during the assessment period 2017-2027. However, it did not reflect slack or negative growth since past years and is likely to show a slow yet an upward rise in the coming years. The revenue generated by global orthobiologics market in 2017 reached US$ 4869 Mn and by the end of the assessment year, it is estimated to reach a value less than US$ 7 Bn. The research study portrays several opportunities in the global orthobiologics market. As mentioned in this study, the rising geriatric population can be considered as a beneficial prospect. Increasing geriatric population offers surplus opportunities for the manufactures of orthobiologics. The major root of amputations are diseases related to ageing as osteoarthritis, musculoskeletal diseases, spine deformity, etc. Increase incidence of accidents owing to increasing urbanization is also a major factor expected to create numerous opportunities for orthobiologics manufacturers. Elevating surgical procedures also presents growth opportunities for the market. The increased incidences of trauma cases, lifestyle related diseases and other chronic disorders have led to rise in number of orthopaedic surgeries at a global level. This growing trend is anticipated to increase the sales of orthobiologics products in present and forthcoming years.
Emergence of online sales channel and government initiatives bot are contributing to the growth of the market. Manufacturers are focussed on creating sales directly through their company’s website to target more customers and without the interference of third-party distributors. This enables the manufacturers to eliminate the variation in product pricing owing to the involvement of third-party suppliers.
Bone graft substitutes continue to exert a hold on the global market
Bone graft substitute segment in the product type category is expected to dominate the global market in the years to follow. This segment was a lucrative one since 2012. During the 2012-2016 timeline, bone graft substitute segment reflected high growth opportunities and led the global market. This trend is observed in the current market scenario and is expected to continue over the period of assessment. In 2017, bone graft substitute segment registered a value of US$ US$ 2521.6 Mn and is according to the growth trend exhibited by this segment, it is estimated to reach a market valuation of above US$ 3 Bn by the end of 2027. During the forecast period of 2017-2027, it is poised to reflect a CAGR of 3.0%.
Xenografts to show high potential for growth adding to the domination of bone graft substitutes
Bone graft substitute segment is further analysed and divided into allograft, xenograft, synthetic and bone morphogenetic protein sub segments. Of these, xenograft sub segment is expected to run at the highest pace to register a meteoric CAGR of 10.0% throughout the period of forecast. This segment is the second largest in terms of market value. Allograft and synthetic sub segments have a large yet almost equal contribution to the revenue of the parent segment. The allograft sub segment is estimated to reach a valuation of US$ 937.5 Mn leading other sub segments. However, the synthetic sub category is poised to grow at a relatively higher rate than allografts in the coming years.
Weighted analysis to achieve strategic proficiency
The market research study on orthobiologics market drafted by Future Market Insights is an extensive research publication that covers the global scenario of orthobiologics market. It includes various macroeconomic factors, opportunity assessment, key growth drivers, restraints and vital segmental analysis. The quantification of data pertaining to these aspects with the help of statistical representations and analysis giving a holistic and an unbiased view of the entire market. The research publication assists the reader in judging the future prospects in orthobiologics across key regions in the globe. Every market segment is assessed in different regions giving a heads up to the reader and assisting in determining revenue pockets for the growth of his/her business. The statistical analysis and forecasting helps in getting a clear market understanding and its scenario in the future based on market acumen of current market standing and historical data. Data mining and number crunching is done with extreme precision to cover analysis of the entire ecosystem of the orthobiologics market. All these insights and qualitative and quantitative analysis of the market is presented in a systematic format in the research report titled “Orthobiologics Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”.
Market Segmentation
The global orthobiologics market is segmented in detail so as to cover every aspect of the market and present a complete market intelligence in front of the reader.
|
By Product Type |
By End User |
By Region |
|---|---|---|
|
|
|
Assumptions used in this research report
While drafting this extensive research report, we have considered market consolidation activities such as merger and acquisition, collaborations, partnerships, which may influence the market growth over a forecast period. Capital expenditure on healthcare infrastructure in the developing economies is also a factor, expected to drives the market. It also rules out impact of extreme events in specific countries. Regulatory impositions such as the rules and regulations by the various regulatory authorities such as U.S. Food and Drug Administration and European Commission could affect the market. Currency fluctuations and changing taxation policies would have a significant impact on forecasting of orthobiologics over the forecast period.
Reasons supporting your investment in this research report
This research study gives a near to 100 percent accurate results pertaining to every segment globally as well as regionally, during the current year as well as 10 years down the line (2017-2027). To ensure data and statistical accuracy, an effective research methodology has been followed that covers extensive secondary research to acquire relevant market details such as overall market size, top players in the industry, top products, important regions, new developments etc., which is validated using primary research to remove deviations and arrive at a data with high precision. This is done by interviewing many industry specialists and subject matter experts, and also the data extracted from company websites, white papers, financial reports etc. All the information gathered is then integrated by Future Market Insights analysts to arrive at final data points pertaining to the global orthobiologics market. The market statistics are presented in a systematic and organised manner with diagrams, graphs etc., which helps the readers grasp the key outcomes at just a single glance. Moreover, a 24x7 analyst support is extended to our clients should the need be.
Orthobiologics Market Reports - Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Orthobiologics Market Viewpoint
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Regulatory scenario
3.4. Porter’s Five Force Analysis
3.5. PESTLE Analysis
4. North America Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) By Country, 2012-2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
4.5.1. Bone Growth Stimulators
4.5.1.1. Non-Invasive Electrical BGS
4.5.1.2. Invasive Electrical BGS
4.5.1.3. Ultrasound BGS
4.5.2. VIscosupplements
4.5.2.1. One Injection VIscosupplements
4.5.2.2. Three Injection VIscosupplements
4.5.2.3. Five Injection VIscosupplements
4.5.3. Bone Graft Substitutes
4.5.3.1. Allografts
4.5.3.2. Synthetics
4.5.3.3. Xenografts
4.5.3.4. Bone Morphogenetic Protein
4.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
4.6.1. Bone Growth Stimulators
4.6.1.1. Non-Invasive Electrical BGS
4.6.1.2. Invasive Electrical BGS
4.6.1.3. Ultrasound BGS
4.6.2. VIscosupplements
4.6.2.1. One Injection VIscosupplements
4.6.2.2. Three Injection VIscosupplements
4.6.2.3. Five Injection VIscosupplements
4.6.3. Bone Graft Substitutes
4.6.3.1. Allografts
4.6.3.2. Synthetics
4.6.3.3. Xenografts
4.6.3.4. Bone Morphogenetic Protein
4.7. Historical Market Size (US$ Mn) By End User, 2012-2016
4.7.1. Hospitals
4.7.2. Ambulatory Surgical Centers
4.7.3. Orthopedic Clinics
4.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
4.8.1. Hospitals
4.8.2. Ambulatory Surgical Centers
4.8.3. Orthopedic Clinics
4.9. Drivers and Restraints: Impact Analysis
4.10. Market Attractiveness Analysis
4.10.1. By Country
4.10.2. By Product Type
4.10.3. By End User
4.11. Key Representative Market Participants
4.12. Key Participants Market Presence (Intensity Map)
5. Latin America Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) By Country, 2012-2016
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Argentina
5.3.4. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Argentina
5.4.4. Rest of Latin America
5.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
5.5.1. Bone Growth Stimulators
5.5.1.1. Non-Invasive Electrical BGS
5.5.1.2. Invasive Electrical BGS
5.5.1.3. Ultrasound BGS
5.5.2. VIscosupplements
5.5.2.1. One Injection VIscosupplements
5.5.2.2. Three Injection VIscosupplements
5.5.2.3. Five Injection VIscosupplements
5.5.3. Bone Graft Substitutes
5.5.3.1. Allografts
5.5.3.2. Synthetics
5.5.3.3. Xenografts
5.5.3.4. Bone Morphogenetic Protein
5.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
5.6.1. Bone Growth Stimulators
5.6.1.1. Non-Invasive Electrical BGS
5.6.1.2. Invasive Electrical BGS
5.6.1.3. Ultrasound BGS
5.6.2. VIscosupplements
5.6.2.1. One Injection VIscosupplements
5.6.2.2. Three Injection VIscosupplements
5.6.2.3. Five Injection VIscosupplements
5.6.3. Bone Graft Substitutes
5.6.3.1. Allografts
5.6.3.2. Synthetics
5.6.3.3. Xenografts
5.6.3.4. Bone Morphogenetic Protein
5.7. Historical Market Size (US$ Mn) By End User, 2012-2016
5.7.1. Hospitals
5.7.2. Ambulatory Surgical Centers
5.7.3. Orthopedic Clinics
5.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
5.8.1. Hospitals
5.8.2. Ambulatory Surgical Centers
5.8.3. Orthopedic Clinics
5.9. Drivers and Restraints: Impact Analysis
5.10. Market Attractiveness Analysis
5.10.1. By Country
5.10.2. By Product Type
5.10.3. By End User
5.11. Key Representative Market Participants
5.12. Key Participants Market Presence (Intensity Map)
6. Western Europe Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) By Country, 2012-2016
6.3.1. Germany
6.3.2. United Kingdom
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Benelux
6.3.7. Nordic Region
6.3.8. Rest of Western Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
6.4.1. Germany
6.4.2. United Kingdom
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Benelux
6.4.7. Nordic Region
6.4.8. Rest of Western Europe
6.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
6.5.1. Bone Growth Stimulators
6.5.1.1. Non-Invasive Electrical BGS
6.5.1.2. Invasive Electrical BGS
6.5.1.3. Ultrasound BGS
6.5.2. VIscosupplements
6.5.2.1. One Injection VIscosupplements
6.5.2.2. Three Injection VIscosupplements
6.5.2.3. Five Injection VIscosupplements
6.5.3. Bone Graft Substitutes
6.5.3.1. Allografts
6.5.3.2. Synthetics
6.5.3.3. Xenografts
6.5.3.4. Bone Morphogenetic Protein
6.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
6.6.1. Bone Growth Stimulators
6.6.1.1. Non-Invasive Electrical BGS
6.6.1.2. Invasive Electrical BGS
6.6.1.3. Ultrasound BGS
6.6.2. VIscosupplements
6.6.2.1. One Injection VIscosupplements
6.6.2.2. Three Injection VIscosupplements
6.6.2.3. Five Injection VIscosupplements
6.6.3. Bone Graft Substitutes
6.6.3.1. Allografts
6.6.3.2. Synthetics
6.6.3.3. Xenografts
6.6.3.4. Bone Morphogenetic Protein
6.7. Historical Market Size (US$ Mn) By End User, 2012-2016
6.7.1. Hospitals
6.7.2. Ambulatory Surgical Centers
6.7.3. Orthopedic Clinics
6.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
6.8.1. Hospitals
6.8.2. Ambulatory Surgical Centers
6.8.3. Orthopedic Clinics
6.9. Drivers and Restraints: Impact Analysis
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Product Type
6.10.3. By End User
6.11. Key Representative Market Participants
6.12. Key Participants Market Presence (Intensity Map)
7. Eastern Europe Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) By Country, 2012-2016
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
7.5.1. Bone Growth Stimulators
7.5.1.1. Non-Invasive Electrical BGS
7.5.1.2. Invasive Electrical BGS
7.5.1.3. Ultrasound BGS
7.5.2. VIscosupplements
7.5.2.1. One Injection VIscosupplements
7.5.2.2. Three Injection VIscosupplements
7.5.2.3. Five Injection VIscosupplements
7.5.3. Bone Graft Substitutes
7.5.3.1. Allografts
7.5.3.2. Synthetics
7.5.3.3. Xenografts
7.5.3.4. Bone Morphogenetic Protein
7.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
7.6.1. Bone Growth Stimulators
7.6.1.1. Non-Invasive Electrical BGS
7.6.1.2. Invasive Electrical BGS
7.6.1.3. Ultrasound BGS
7.6.2. VIscosupplements
7.6.2.1. One Injection VIscosupplements
7.6.2.2. Three Injection VIscosupplements
7.6.2.3. Five Injection VIscosupplements
7.6.3. Bone Graft Substitutes
7.6.3.1. Allografts
7.6.3.2. Synthetics
7.6.3.3. Xenografts
7.6.3.4. Bone Morphogenetic Protein
7.7. Historical Market Size (US$ Mn) By End User, 2012-2016
7.7.1. Hospitals
7.7.2. Ambulatory Surgical Centers
7.7.3. Orthopedic Clinics
7.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
7.8.1. Hospitals
7.8.2. Ambulatory Surgical Centers
7.8.3. Orthopedic Clinics
7.9. Drivers and Restraints: Impact Analysis
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Product Type
7.10.3. By End User
7.11. Key Representative Market Participants
7.12. Key Participants Market Presence (Intensity Map)
8. Asia Pacific excluding Japan Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) By Country, 2012-2016
8.3.1. China
8.3.2. India
8.3.3. Australia and New Zealand
8.3.4. ASEAN
8.3.5. Rest of APEJ
8.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
8.4.1. China
8.4.2. India
8.4.3. Australia and New Zealand
8.4.4. ASEAN
8.4.5. Rest of APEJ
8.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
8.5.1. Bone Growth Stimulators
8.5.1.1. Non-Invasive Electrical BGS
8.5.1.2. Invasive Electrical BGS
8.5.1.3. Ultrasound BGS
8.5.2. VIscosupplements
8.5.2.1. One Injection VIscosupplements
8.5.2.2. Three Injection VIscosupplements
8.5.2.3. Five Injection VIscosupplements
8.5.3. Bone Graft Substitutes
8.5.3.1. Allografts
8.5.3.2. Synthetics
8.5.3.3. Xenografts
8.5.3.4. Bone Morphogenetic Protein
8.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
8.6.1. Bone Growth Stimulators
8.6.1.1. Non-Invasive Electrical BGS
8.6.1.2. Invasive Electrical BGS
8.6.1.3. Ultrasound BGS
8.6.2. VIscosupplements
8.6.2.1. One Injection VIscosupplements
8.6.2.2. Three Injection VIscosupplements
8.6.2.3. Five Injection VIscosupplements
8.6.3. Bone Graft Substitutes
8.6.3.1. Allografts
8.6.3.2. Synthetics
8.6.3.3. Xenografts
8.6.3.4. Bone Morphogenetic Protein
8.7. Historical Market Size (US$ Mn) By End User, 2012-2016
8.7.1. Hospitals
8.7.2. Ambulatory Surgical Centers
8.7.3. Orthopedic Clinics
8.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
8.8.1. Hospitals
8.8.2. Ambulatory Surgical Centers
8.8.3. Orthopedic Clinics
8.9. Drivers and Restraints: Impact Analysis
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By End User
8.11. Key Representative Market Participants
8.12. Key Participants Market Presence (Intensity Map)
9. Japan Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Regional Market Dynamics
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Historical Market Size (US$ Mn) By Product Type, 2012-2016
9.3.1. Bone Growth Stimulators
9.3.1.1. Non-Invasive Electrical BGS
9.3.1.2. Invasive Electrical BGS
9.3.1.3. Ultrasound BGS
9.3.2. VIscosupplements
9.3.2.1. One Injection VIscosupplements
9.3.2.2. Three Injection VIscosupplements
9.3.2.3. Five Injection VIscosupplements
9.3.3. Bone Graft Substitutes
9.3.3.1. Allografts
9.3.3.2. Synthetics
9.3.3.3. Xenografts
9.3.3.4. Bone Morphogenetic Protein
9.4. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
9.4.1. Bone Growth Stimulators
9.4.1.1. Non-Invasive Electrical BGS
9.4.1.2. Invasive Electrical BGS
9.4.1.3. Ultrasound BGS
9.4.2. VIscosupplements
9.4.2.1. One Injection VIscosupplements
9.4.2.2. Three Injection VIscosupplements
9.4.2.3. Five Injection VIscosupplements
9.4.3. Bone Graft Substitutes
9.4.3.1. Allografts
9.4.3.2. Synthetics
9.4.3.3. Xenografts
9.4.3.4. Bone Morphogenetic Protein
9.5. Historical Market Size (US$ Mn) By End User, 2012-2016
9.5.1. Hospitals
9.5.2. Ambulatory Surgical Centers
9.5.3. Orthopedic Clinics
9.6. Market Size (US$ Mn) Forecast By End User, 2017-2027
9.6.1. Hospitals
9.6.2. Ambulatory Surgical Centers
9.6.3. Orthopedic Clinics
9.7. Drivers and Restraints: Impact Analysis
9.8. Market Attractiveness Analysis
9.8.1. By Product Type
9.8.2. By End User
9.9. Key Representative Market Participants
9.10. Key Participants Market Presence (Intensity Map)
10. Middle East & Africa Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction
10.2. Regional Market Dynamics
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3. Historical Market Size (US$ Mn) By Country, 2012-2016
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of MEA
10.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of MEA
10.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
10.5.1. Bone Growth Stimulators
10.5.1.1. Non-Invasive Electrical BGS
10.5.1.2. Invasive Electrical BGS
10.5.1.3. Ultrasound BGS
10.5.2. VIscosupplements
10.5.2.1. One Injection VIscosupplements
10.5.2.2. Three Injection VIscosupplements
10.5.2.3. Five Injection VIscosupplements
10.5.3. Bone Graft Substitutes
10.5.3.1. Allografts
10.5.3.2. Synthetics
10.5.3.3. Xenografts
10.5.3.4. Bone Morphogenetic Protein
10.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
10.6.1. Bone Growth Stimulators
10.6.1.1. Non-Invasive Electrical BGS
10.6.1.2. Invasive Electrical BGS
10.6.1.3. Ultrasound BGS
10.6.2. VIscosupplements
10.6.2.1. One Injection VIscosupplements
10.6.2.2. Three Injection VIscosupplements
10.6.2.3. Five Injection VIscosupplements
10.6.3. Bone Graft Substitutes
10.6.3.1. Allografts
10.6.3.2. Synthetics
10.6.3.3. Xenografts
10.6.3.4. Bone Morphogenetic Protein
10.7. Historical Market Size (US$ Mn) By End User, 2012-2016
10.7.1. Hospitals
10.7.2. Ambulatory Surgical Centers
10.7.3. Orthopedic Clinics
10.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
10.8.1. Hospitals
10.8.2. Ambulatory Surgical Centers
10.8.3. Orthopedic Clinics
10.9. Drivers and Restraints: Impact Analysis
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By End User
10.11. Key Representative Market Participants
10.12. Key Participants Market Presence (Intensity Map)
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1. Market Structure
13.2. Market Share Analysis
13.3. Competition Dashboard
13.4. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
13.4.1. Medtronic plc
13.4.2. NuVasive, Inc.
13.4.3. Stryker Corporation
13.4.4. Zimmer Biomet Holdings
13.4.5. Orthofix International N.V.
13.4.6. Anika Therapeutics, Inc.
13.4.7. DePuy Synthes (Johnson & Johnson)
13.4.8. Bioventus
13.4.9. Arthrex, Inc.
13.4.10. SeaSpine Holdings Corporation
13.4.11. Sanofi-Aventis (Sanofi SA)
13.4.12. Djo Global, Inc.
13.4.13. Seikagaku Corporation
13.4.14. RTI Surgical, Inc.
13.4.15. Heraeus Holding GmbH
13.4.16. Fidia Pharma USA Inc.
13.4.17. TRB Chemedica International SA
13.4.18. Allosource
13.4.19. Musculoskeletal Transplant Foundation, Inc.
13.4.20. Ito Co., Ltd.
14. Global Orthobiologics Market Analysis and Forecast, By Region
14.1. Introduction
14.2. Historical Market Size (US$ Mn) By Region, 2012-2016
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Asia Pacific Excl. Japan (APEJ)
14.2.6. Japan
14.2.7. Middle East and Africa (MEA)
14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Asia Pacific Excl. Japan (APEJ)
14.3.6. Japan
14.3.7. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis By Region
15. Global Orthobiologics Market Analysis and Forecast, By Product Type
15.1. Introduction
15.2. Historical Market Size (US$ Mn) By Product Type, 2012-2016
15.2.1. Bone Growth Stimulators
15.2.1.1. Non-Invasive Electrical BGS
15.2.1.2. Invasive Electrical BGS
15.2.1.3. Ultrasound BGS
15.2.2. VIscosupplements
15.2.2.1. One Injection VIscosupplements
15.2.2.2. Three Injection VIscosupplements
15.2.2.3. Five Injection VIscosupplements
15.2.3. Bone Graft Substitutes
15.2.3.1. Allografts
15.2.3.2. Synthetics
15.2.3.3. Xenografts
15.2.3.4. Bone Morphogenetic Protein
15.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
15.3.1. Bone Growth Stimulators
15.3.1.1. Non-Invasive Electrical BGS
15.3.1.2. Invasive Electrical BGS
15.3.1.3. Ultrasound BGS
15.3.2. VIscosupplements
15.3.2.1. One Injection VIscosupplements
15.3.2.2. Three Injection VIscosupplements
15.3.2.3. Five Injection VIscosupplements
15.3.3. Bone Graft Substitutes
15.3.3.1. Allografts
15.3.3.2. Synthetics
15.3.3.3. Xenografts
15.3.3.4. Bone Morphogenetic Protein
15.4. Market Attractiveness Analysis By Product Type
16. Global Orthobiologics Market Analysis and Forecast, By End User
16.1. Introduction
16.2. Historical Market Size (US$ Mn) By End User, 2012-2016
16.2.1. Hospital
16.2.2. Ambulatory Surgical Centers
16.2.3. Orthopedic Clinics
16.3. Market Size (US$ Mn) Forecast By End User, 2017-2027
16.3.1. Hospital Pharmacies
16.3.2. Retail Pharmacies
16.3.3. Online Pharmacies
16.4. Market Attractiveness Analysis By End User
17. Global Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
17.1. Market Size and Y-o-Y Growth
17.2. Absolute $ Opportunity
18. Assumptions and Acronyms Used
19. Research Methodology
Orthobiologics Market Reports - List of Tables
Table 01: North America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 02: North America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 03: North America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 04: Latin America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 05: Latin America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 06: Latin America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 07: Western Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 08: Western Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 09: Western Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 10: Eastern Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 11: Eastern Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 12: Eastern Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 13: APEJ Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 14: APEJ Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 15: APEJ Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 16: Japan Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 17: Japan Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 18: MEA Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 19: MEA Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 20: MEA Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 21: Global Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Region
Table 22: Global Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 23: Global Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Orthobiologics Market Reports - List of Figures
Figure 01: North America Orthobiologics Market Value Share By Product Type (2017)
Figure 02: North America Orthobiologics Market Value Share By End User (2017)
Figure 03: North America Orthobiologics Market Value Share By Country (2017)
Figure 04: North America Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 05: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Figure 06: U.S. Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 08: Canada Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 07: U.S. Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 09: Canada Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 10: North America Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016
Figure 11: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027
Figure 12: North America Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016
Figure 13: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027
Figure 14: North America Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016
Figure 15: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027
Figure 16: North America Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016
Figure 17: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027
Figure 18: North America Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016
Figure 19: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027
Figure 20: North America Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016
Figure 21: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027
Figure 22: North America Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027
Figure 23: North America Orthobiologics Market Attractiveness Analysis By End User, 2017–2027
Figure 24: North America Orthobiologics Market Attractiveness Analysis By Country, 2017–2027
Figure 25: Latin America Orthobiologics Market Value Share By Product Type (2017)
Figure 26: Latin America Orthobiologics Market Value Share By End User (2017)
Figure 27: Latin America Orthobiologics Market Value Share By Country (2017)
Figure 28: Latin America Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 29: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Figure 30: Brazil Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 31: Brazil Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 32: Mexico Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 33: Mexico Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 34: Argentina Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 35: Argentina Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 36: Rest of Latin America Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 37: Rest of Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 38: Latin America Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016
Figure 39: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027
Figure 40: Latin America Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016
Figure 41: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027
Figure 42: Latin America Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016
Figure 43: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027
Figure 44: Latin America Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016
Figure 45: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027
Figure 46: Latin America Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016
Figure 47: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027
Figure 48: Latin America Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016
Figure 49: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027
Figure 50: Latin America Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027
Figure 51: Latin America Orthobiologics Market Attractiveness Analysis By End User, 2017–2027
Figure 52: North America Orthobiologics Market Attractiveness Analysis By Country, 2017–2027
Figure 53: Western Europe Orthobiologics Market Value Share By Product Type (2017)
Figure 54: Western Europe Orthobiologics Market Value Share By End User (2017)
Figure 55: Western Europe Orthobiologics Market Value Share By Country (2017)
Figure 56: Western Europe Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 57: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Figure 58: UK Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 59: UK Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 60: Germany Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 61: Germany Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 62: France Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 63: France Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 64: Italy Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 65: Italy Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 66: Spain Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 67: Spain Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 68: Nordic Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 69: Nordic Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 70: BENELUX Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 71: BENELUX Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 72: Rest of Western Europe Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 73: Rest of Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 74: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016
Figure 75: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027
Figure 76: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016
Figure 77: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027
Figure 78: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016
Figure 79: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027
Figure 80: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016
Figure 81: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027
Figure 82: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016
Figure 83: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027
Figure 84: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016
Figure 85: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027
Figure 86: Western Europe Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027
Figure 87: Western Europe Orthobiologics Market Attractiveness Analysis By End User, 2017–2027
Figure 88: Western Europe Orthobiologics Market Attractiveness Analysis By Country, 2017–2027
Figure 89: Eastern Europe Orthobiologics Market Value Share By Product Type (2017)
Figure 90: Eastern Europe Orthobiologics Market Value Share By End User (2017)
Figure 91: Eastern Europe Orthobiologics Market Value Share By Country (2017)
Figure 92: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 93: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Figure 94: Russia Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 95: Russia Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 96: Poland Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 97: Poland Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 98: Rest of Eastern Europe Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 99: Rest of Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 100: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016
Figure 101: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027
Figure 102: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016
Figure 103: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027
Figure 104: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016
Figure 105: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027
Figure 106: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016
Figure 107: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027
Figure 108: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016
Figure 109: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027
Figure 110: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016
Figure 111: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027
Figure 112: Eastern Europe Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027
Figure 113: Eastern Europe Orthobiologics Market Attractiveness Analysis By End User, 2017–2027
Figure 114: Eastern Europe Orthobiologics Market Attractiveness Analysis By Country, 2017–2027
Figure 115: APEJ Orthobiologics Market Value Share By Product Type (2017)
Figure 116: APEJ Orthobiologics Market Value Share By End User (2017)
Figure 117: APEJ Orthobiologics Market Value Share By Country (2017)
Figure 118: APEJ Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 119: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Figure 120: China Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 121: China Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 122: India Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 123: India Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 124: ANZ Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 125: ANZ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 126: ASEAN Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 127: ASEAN Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 128: Rest of APEJ Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 129: Rest of APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 130: APEJ Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016
Figure 131: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027
Figure 132: APEJ Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016
Figure 133: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027
Figure 134: APEJ Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016
Figure 135: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027
Figure 136: APEJ Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016
Figure 137: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027
Figure 138: APEJ Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016
Figure 139: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027
Figure 140: APEJ Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016
Figure 141: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027
Figure 142: APEJ Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027
Figure 143: APEJ Orthobiologics Market Attractiveness Analysis By End User, 2017–2027
Figure 144: APEJ Orthobiologics Market Attractiveness Analysis By Country, 2017–2027
Figure 145: Japan Orthobiologics Market Value Share By Product Type (2017)
Figure 146: Japan Orthobiologics Market Value Share By End User (2017)
Figure 147: Japan Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 148: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Figure 149: Japan Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016
Figure 150: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027
Figure 151: Japan Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016
Figure 152: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027
Figure 153: Japan Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016
Figure 154: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027
Figure 155: Japan Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016
Figure 156: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027
Figure 157: Japan Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016
Figure 158: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027
Figure 159: Japan Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016
Figure 160: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027
Figure 161: Japan Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027
Figure 162: Japan Orthobiologics Market Attractiveness Analysis By End User, 2017–2027
Figure 163: MEA Orthobiologics Market Value Share By Product Type (2017)
Figure 164: MEA Orthobiologics Market Value Share By End User (2017)
Figure 165: MEA Orthobiologics Market Value Share By Country (2017)
Figure 166: MEA Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 167: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Figure 168: South Africa Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 169: South Africa Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 170: GCC Countries Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 171: GCC Countries Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 172: Rest of MEA Orthobiologics Historical Market Size (US$ Mn), 2012–2016
Figure 173: Rest of MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 174: MEA Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016
Figure 175: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027
Figure 176: MEA Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016
Figure 177: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027
Figure 178: MEA Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016
Figure 179: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027
Figure 180: MEA Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016
Figure 181: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027
Figure 182: MEA Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016
Figure 183: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027
Figure 184: MEA Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016
Figure 185: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027
Figure 186: MEA Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027
Figure 187: MEA Orthobiologics Market Attractiveness Analysis By End User, 2017–2027
Figure 188: MEA Orthobiologics Market Attractiveness Analysis By Country, 2017–2027
Figure 189: Global Orthobiologics Market Y-o-Y Growth (%) 2017–2027, By Region
Figure 190: Global Orthobiologics Market Attractiveness Analysis By Region, 2017–2027
Figure 191: Global Orthobiologics Market Y-o-Y Growth (%) 2017–2027, By Product Type
Figure 192: Global Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulation, 2012–2016
Figure 193: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulation, 2017–2027
Figure 194: Global Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016
Figure 195: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027
Figure 196: Global Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016
Figure 197: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Subsitute, 2017–2027
Figure 198: Global Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027
Figure 199: Global Orthobiologics Market Y-o-Y Growth (%) 2017–2027, By End User
Figure 200: Global Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016
Figure 201: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027
Figure 202: Global Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016
Figure 203: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027
Figure 204: Global Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016
Figure 205: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027
Figure 206: Global Orthobiologics Market Attractiveness Analysis By End User, 2017–2027
Figure 207: Global Orthobiologics Market Value Analysis and Forecast, 2016–2027 (US$ Mn)
Figure 208: Global Orthobiologics Market Value (US$ Mn), 2012–2016
Figure 209: Global Orthobiologics Market Absolute $ Opportunity (US$ Mn), 2016–2027